This track focuses on the unique dermatological conditions affecting neonates, including neonatal nutrition and its impact on skin health. Discussions will include advancements in the management of bilirubin encephalopathy and neonatal polycythemia.

This session will explore the genetic basis of various genodermatoses and their implications for pediatric patients. Emphasis will be placed on novel therapeutic strategies and the role of genetic counseling.

This track will delve into the pathophysiology of acne in children and adolescents, examining the psychosocial impacts and treatment modalities. Participants will discuss evidence-based approaches to managing this common condition.

This session will address the clinical management of warts and vitiligo in pediatric patients, highlighting recent advancements in treatment options. The discussion will also cover the psychosocial implications of these conditions.

This track will focus on the diagnosis and management of bacterial skin infections in pediatric populations. Participants will explore emerging trends in antibiotic resistance and its impact on treatment outcomes.

This session will examine the epidemiology of fungal skin infections in children and the latest therapeutic strategies. Discussions will include the challenges of diagnosis and the role of antifungal agents.